GenTrust LLC Purchases 280 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

GenTrust LLC raised its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 0.1% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 189,672 shares of the exchange traded fund’s stock after purchasing an additional 280 shares during the quarter. SPDR S&P Biotech ETF accounts for approximately 0.7% of GenTrust LLC’s holdings, making the stock its 28th biggest position. GenTrust LLC owned about 0.30% of SPDR S&P Biotech ETF worth $15,382,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Addison Advisors LLC grew its holdings in SPDR S&P Biotech ETF by 27.4% during the fourth quarter. Addison Advisors LLC now owns 535 shares of the exchange traded fund’s stock valued at $48,000 after purchasing an additional 115 shares during the period. Bourgeon Capital Management LLC raised its stake in SPDR S&P Biotech ETF by 6.1% during the 1st quarter. Bourgeon Capital Management LLC now owns 2,822 shares of the exchange traded fund’s stock worth $229,000 after acquiring an additional 163 shares during the period. Arlington Financial Advisors LLC raised its stake in SPDR S&P Biotech ETF by 0.8% during the 1st quarter. Arlington Financial Advisors LLC now owns 22,685 shares of the exchange traded fund’s stock worth $1,840,000 after acquiring an additional 181 shares during the period. Institute for Wealth Management LLC. lifted its holdings in SPDR S&P Biotech ETF by 2.0% during the first quarter. Institute for Wealth Management LLC. now owns 9,676 shares of the exchange traded fund’s stock valued at $785,000 after purchasing an additional 186 shares in the last quarter. Finally, RPg Family Wealth Advisory LLC boosted its position in shares of SPDR S&P Biotech ETF by 1.1% in the fourth quarter. RPg Family Wealth Advisory LLC now owns 17,904 shares of the exchange traded fund’s stock worth $1,612,000 after purchasing an additional 200 shares during the period.

SPDR S&P Biotech ETF Price Performance

Shares of NYSEARCA XBI opened at $83.27 on Thursday. The firm has a fifty day moving average price of $80.64 and a 200-day moving average price of $85.41. The stock has a market cap of $4.48 billion, a PE ratio of 11.47 and a beta of 0.85. SPDR S&P Biotech ETF has a 1 year low of $66.66 and a 1 year high of $105.47.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.